Hemanext:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Hemanext - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10530
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Hemanext, formerly New Health Sciences Inc, is a medical technology company that develops blood storage systems. The company offers an anaerobic storage system that minimizes oxidative damage to red blood cells in storage and delivers physiologic, therapeutic, and fresher red blood cell than conventional storage systems. It develops a storage system for red blood cells and whole blood, which is designed to preserve their value and safety characteristics during storage, and extends potential storage life. Hemanext offers microvascular analyzer, which is a new test and measurement system that provides both researchers and clinicians a measure of RBC deformability in a simulated capillary network using very small samples. The company collaborates with research organizations to conduct research activities. It caters to blood centers, patients, hospitals and researchers. Hemanext is headquartered in Lexington, Maryland, the US.

Hemanext – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Hemanext, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hemanext, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Hemanext, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hemanext, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Hemanext, Medical Devices Deals, 2012 to YTD 2018 9
Hemanext, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Hemanext, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Hemanext Raises USD2 Million in Venture Financing 11
New Health Sciences Raises USD2 Million in Venture Financing 12
Hemanext Raises USD2.7 Million in Venture Financing 13
Hemanext – Key Competitors 14
Hemanext – Key Employees 15
Hemanext – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Strategy And Business Planning 17
Oct 04, 2017: New Health Sciences Announces Company Name Change to Hemanext 17
Product News 18
Mar 06, 2017: Wide Distribution of Initial Oxygen Saturation Levels in Red Cells Stored for Transfusion, May Significantly Influence Cell Quality and Therapeutic Efficacy 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Hemanext, Pharmaceuticals & Healthcare, Key Facts 2
Hemanext, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hemanext, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Hemanext, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hemanext, Deals By Therapy Area, 2012 to YTD 2018 8
Hemanext, Medical Devices Deals, 2012 to YTD 2018 9
Hemanext, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Hemanext Raises USD2 Million in Venture Financing 11
New Health Sciences Raises USD2 Million in Venture Financing 12
Hemanext Raises USD2.7 Million in Venture Financing 13
Hemanext, Key Competitors 14
Hemanext, Key Employees 15
Hemanext, Subsidiaries 16

List of Figures
Hemanext, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Hemanext, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Hemanext, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Hemanext, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Hemanext, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hemanext, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Hemanext, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hemanext, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Hemanext, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Hemanext:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Greencore Group Plc:戦略・SWOT・企業財務分析
    Greencore Group Plc - Strategy, SWOT and Corporate Finance Report Summary Greencore Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Ramsay Health Care Limited:企業の戦略・SWOT・財務分析
    Ramsay Health Care Limited - Strategy, SWOT and Corporate Finance Report Summary Ramsay Health Care Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Mimetogen Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Mimetogen Pharmaceuticals Inc (Mimetogen) is a clinical stage biotechnology company that develops the use of peptidomimetics for the treatment of ophthalmic diseases. The company’s lead compound, MIM-D3, which is in Phase 3 clinical study used for the treatment of dry eye syndrome. It also o …
  • Avanti Energy Inc (AVN):石油・ガス:M&Aディール及び事業提携情報
    Summary Avanti Energy Inc (Avanti Energy), formerly Overlord Capital Ltd is an oil and gas exploration and production company. The company acquires, explores and develops gas reserves in Central Italy. It re-develops the existing oil and gas reserves. Avanti Energy re-enters and drills new wells in …
  • Acticor Biotech SAS-製薬・医療分野:企業M&A・提携分析
    Summary Acticor Biotech SAS (Acticor), a subsidiary of MabDesign is a biopharmaceutical company that develops innovative therapeutic strategy for the emergency treatment of ischemic strokes. The company provides Fab product that provides monoclonal antibody targeting solutions through platelet glyco …
  • Innsuites Hospitality Trust:企業の戦略・SWOT・財務分析
    Innsuites Hospitality Trust - Strategy, SWOT and Corporate Finance Report Summary Innsuites Hospitality Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Harvey Gulf International Marine LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Harvey Gulf International Marine LLC (Harvey Gulf), formerly Harvey Canal Towing Company is a marine transportation company that provides offshore supply and multi-purpose support vessels for deep-water operations. The company offers offshore supply vessel services, offshore mooring line sup …
  • Tyco International plc:企業のM&A・事業提携・投資動向
    Tyco International plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Tyco International plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Engineers India Ltd (ENGINERSIN):企業の財務・戦略的SWOT分析
    Engineers India Ltd (ENGINERSIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Plenus Company Limited
    Plenus Company Limited - Strategy, SWOT and Corporate Finance Report Summary Plenus Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Aesculap Inc-医療機器分野:企業M&A・提携分析
    Summary Aesculap Inc (Aesculap) is a medical device company that offers medical implants, surgical implants, and other related devices. The company’s products comprise neurosurgery products, power systems, sterile processing products, surgical instruments, and wound closure products. It offers servi …
  • bluebird bio Inc (BLUE):企業の財務・戦略的SWOT分析
    bluebird bio Inc (BLUE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • CommScope Holding Company Inc (COMM):企業の財務・戦略的SWOT分析
    CommScope Holding Company Inc (COMM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Prosetta Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Prosetta Biosciences Inc (Prosetta Biosciences), formerly Prosetta Antiviral Inc is a developer of novel small-molecule antiviral drugs based on research on the cell-free protein synthesizing systems. The company uses cell-free protein synthesizing systems to identify new protein-protein int …
  • Singapore Power Ltd:企業の戦略的SWOT分析
    Singapore Power Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Canadian Energy Services & Technology Corp. (CEU):石油・ガス:M&Aディール及び事業提携情報
    Summary Canadian Energy Services & Technology Corp (CES) is a provider of chemical solutions. It provides technically advanced consumable chemical solutions for the North American oil and gas industry. The total solution provided by the company includes the drill-bit, at the point of completion and …
  • Nasdaq, Inc. (NDAQ):企業の財務・戦略的SWOT分析
    Nasdaq, Inc. (NDAQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Compal Electronics, Inc.:企業の戦略・SWOT・財務情報
    Compal Electronics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Compal Electronics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Fitbit Inc.:企業の戦略・SWOT・財務情報
    Fitbit Inc. - Strategy, SWOT and Corporate Finance Report Summary Fitbit Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Hitachi High-Technologies Corp (8036):企業の財務・戦略的SWOT分析
    Hitachi High-Technologies Corp (8036) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆